NCT01053767View on ClinicalTrials.gov

A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2010

Conditions
Group B Streptococcus (GBS) Disease
Interventions
BIOLOGICAL

Group B streptococcus (GBS) vaccine

"No vaccine will be administered in this study. Only one study visit is required.~Subjects will return to the clinic for a single visit at 24 months (± 3 months) after the last injection administered in the V98P2 study."

Trial Locations (1)

Unknown

Institute for Pharmacokinetic and Analytical Studies, Via Mastri, 36

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY